Chronic lymphocytic leukaemia: diagnosis and management
You must score at least 70% in this module to pass. Ensure you have read ‘Chronic lymphocytic leukaemia: diagnosis and management’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
What is the incidence of CLL in the UK?
CorrectIncorrect - Question 2 of 15
2. Question
Which of the following factors are not implicated in pathogenesis of CLL?
CorrectIncorrect - Question 3 of 15
3. Question
Which of the following statements is accurate about the diagnosis of CLL?
CorrectIncorrect - Question 4 of 15
4. Question
Which immunophenotype best describes CLL phenotype?
CorrectIncorrect - Question 5 of 15
5. Question
Which cytogenetic abnormality is associated with worst prognosis in CLL?
CorrectIncorrect - Question 6 of 15
6. Question
Which cytogenetic abnormality is associated with most favourable prognosis in CLL?
CorrectIncorrect - Question 7 of 15
7. Question
Which statement best describes use of imaging in CLL?
CorrectIncorrect - Question 8 of 15
8. Question
How are newly diagnosed patients with CLL who do not meet the 2018 iwCLL criteria to initiate treatment managed?
CorrectIncorrect - Question 9 of 15
9. Question
Which of the below combination was used in the experimental arm of CLL14 trial?
CorrectIncorrect - Question 10 of 15
10. Question
What initial treatment, according to British Committee for Standards in Haematology guidelines, would you recommend for someone of is fit and well, with an intact TP53 mutation, IGHV unmutated status?
CorrectIncorrect - Question 11 of 15
11. Question
Which of the following combination treatment is approved by NHS England /Cancer Drugs Fund in England for relapsed/refractory CLL?
CorrectIncorrect - Question 12 of 15
12. Question
Which of the following is a common complication of BTKi treatment?
CorrectIncorrect - Question 13 of 15
13. Question
What are the characteristic features of tumour lysis syndrome?
CorrectIncorrect - Question 14 of 15
14. Question
When would you use IV immunoglobulin replacement for individual situations of hypogammaglobulinemia and repeated infections in patients with CLL, according to NHS England guidelines?
CorrectIncorrect - Question 15 of 15
15. Question
Which of the following statements regarding vaccinations in patients with CLL is true?
CorrectIncorrect